Shareholding disclosure

Thomas Meier

Declared position

3.12%

Threshold

Crossed upwards

Timeline

Published

24.03.2015

Transaction

17.03.2015

Voting rights breakdown

Voting rights acquired3.12%

Voting rights sold0%

Below threshold0%

Notice details

CategorySingle shareholder

ExchangeXSWX

Notification ID

TAF3I00046

Beneficial owner

Thomas Meier

Declared address

Thomas Meier, 4056 Basel

Grant of employee stock options

Open shareholder profile Open company profile

Back to the feed

Shareholding disclosure

Thomas Meier

Santhera Pharmaceuticals Holding AG24.03.2015TAF3I00046

Disclosure summary

Thomas Meier disclosed a holding in Santhera Pharmaceuticals Holding AG on the acquisition side, published by SIX Exchange Regulation on 24.03.2015, at 3.12% of voting rights. Notice category: Single shareholder.

Disclosed position

3.12%

Voting rights acquired

Voting rights acquired3.12%

Voting rights sold0%

Below threshold0%

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open

Disclosure detail

Thomas Meier disclosed a holding in Santhera Pharmaceuticals Holding AG, published on 24.03.2015.

Publication date24.03.2015

Transaction date17.03.2015

Issuing companySanthera Pharmaceuticals Holding AG

Beneficial ownerThomas Meier

Declared addressThomas Meier, 4056 Basel

CategorySingle shareholder

Voting rights acquired3.12%

Voting rights sold0%

Below threshold0%

ExchangeXSWX

Notification IDTAF3I00046

Conditions

Grant of employee stock options

Source: SIX Exchange Regulation · Publication date: 24.03.2015

These figures aggregate public disclosures. They are not investment advice.

insider24.ch

Never miss a market signal again

Create a free account

Need more? Discover the Pro plan

Pro alertsEmail and Telegram after publication

Unlimited company trackingUnlimited watchlist with the Pro plan

Monday recapYour stocks' essentials at the open